An overview of treatment for atrial septal defect with pulmonary hypertension

Veronika Anjelina Aho Gudi, Luh Oliva Saraswati Suastika, C. Sinardja
{"title":"An overview of treatment for atrial septal defect with pulmonary hypertension","authors":"Veronika Anjelina Aho Gudi, Luh Oliva Saraswati Suastika, C. Sinardja","doi":"10.33024/minh.v6i7.13212","DOIUrl":null,"url":null,"abstract":"Background: Atrial Septal Defect (ASD) is a congenital heart defect which can be the cause of comorbidities in the form of Pulmonary Arterial Hypertension (PAH) and therapy cannot be done simply by correcting the ASD but requires further study and evaluation.Purpose: Describe the treatment given to patients with ASD and PAH and the correlation between the administration of interventional therapy and the patient's probability of PH.Method: This study is a descriptive quantitative using a cross-sectional research design. The sampling technique was total sampling method. The samples were 41 ASD patients with PAH at Prof. Ngoerah General Hospital in Denpasar in 2022. Patients under 18 years of age and those with other congenital heart disease will be excluded. The demographic characteristics assessed were the patient's age and gender. The therapy data included information on medical therapy and intervention therapy.Results: Focus of medical therapy was supportive therapy rather than specific PAH therapy. Percutaneous ASD closure was the most widely-used intervention therapy compared to surgical ASD closure. Based on statistical analysis, the p value > 0.05 is 0.284, so there is no significant correlation between the probability of the patient's pH and the provision of intervention therapy.Conclusion: At Prof Ngoerah General Hospital Denpasar, the majority of ASD patients with complications of pulmonary hypertension were females aged between 21 to 30 years. The medical therapy given is adjusted based on the severity of PH as assessed through echocardiography examination. Majority of patients received supportive therapy compared to specific therapy for PAH. Medical therapy is prioritized for patients who have contraindication criteria for interventional therapy. Percutaneous ASD Closure was found to be the largest percentage in interventional therapy regardless of the severity, except for patients who were indicated to undergo surgical ASD closure. There is no significant relationship between the patient's PH probability level and the choice of intervention therapy.","PeriodicalId":18172,"journal":{"name":"Malahayati International Journal of Nursing and Health Science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malahayati International Journal of Nursing and Health Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33024/minh.v6i7.13212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Atrial Septal Defect (ASD) is a congenital heart defect which can be the cause of comorbidities in the form of Pulmonary Arterial Hypertension (PAH) and therapy cannot be done simply by correcting the ASD but requires further study and evaluation.Purpose: Describe the treatment given to patients with ASD and PAH and the correlation between the administration of interventional therapy and the patient's probability of PH.Method: This study is a descriptive quantitative using a cross-sectional research design. The sampling technique was total sampling method. The samples were 41 ASD patients with PAH at Prof. Ngoerah General Hospital in Denpasar in 2022. Patients under 18 years of age and those with other congenital heart disease will be excluded. The demographic characteristics assessed were the patient's age and gender. The therapy data included information on medical therapy and intervention therapy.Results: Focus of medical therapy was supportive therapy rather than specific PAH therapy. Percutaneous ASD closure was the most widely-used intervention therapy compared to surgical ASD closure. Based on statistical analysis, the p value > 0.05 is 0.284, so there is no significant correlation between the probability of the patient's pH and the provision of intervention therapy.Conclusion: At Prof Ngoerah General Hospital Denpasar, the majority of ASD patients with complications of pulmonary hypertension were females aged between 21 to 30 years. The medical therapy given is adjusted based on the severity of PH as assessed through echocardiography examination. Majority of patients received supportive therapy compared to specific therapy for PAH. Medical therapy is prioritized for patients who have contraindication criteria for interventional therapy. Percutaneous ASD Closure was found to be the largest percentage in interventional therapy regardless of the severity, except for patients who were indicated to undergo surgical ASD closure. There is no significant relationship between the patient's PH probability level and the choice of intervention therapy.
房间隔缺损合并肺动脉高压治疗概述
背景:目的:描述 ASD 和 PAH 患者的治疗方法,以及介入治疗与患者 PH 概率之间的相关性:本研究为描述性定量研究,采用横断面研究设计。抽样技术为总体抽样法。样本为 2022 年在登巴萨恩圭拉教授综合医院就诊的 41 名患有 PAH 的 ASD 患者。18岁以下和患有其他先天性心脏病的患者将被排除在外。评估的人口统计学特征包括患者的年龄和性别。治疗数据包括药物治疗和干预治疗的信息:结果:医学治疗的重点是支持性治疗,而非特定的 PAH 治疗。与外科ASD闭合术相比,经皮ASD闭合术是使用最广泛的干预疗法。根据统计分析,P 值 > 0.05 为 0.284,因此患者 pH 值的概率与干预治疗的提供之间没有明显的相关性:在登巴萨恩圭拉教授综合医院,并发肺动脉高压的 ASD 患者大多为女性,年龄在 21 至 30 岁之间。根据超声心动图检查评估出的肺动脉高压严重程度,对所提供的药物治疗进行调整。与针对 PAH 的特殊治疗相比,大多数患者接受的是支持性治疗。对于有介入治疗禁忌症的患者,则优先考虑药物治疗。经皮 ASD 关闭术在介入治疗中所占比例最大,无论其严重程度如何,但有指征接受手术 ASD 关闭术的患者除外。患者的 PH 概率水平与选择介入疗法之间没有明显关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信